BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36067507)

  • 1. Prognostic factors and outcomes of infant acute lymphoblastic leukemia (ALL), hypodiploid ALL, and mixed-phenotype acute leukemia (MPAL) in Canada: a report from CYP-C.
    Tibout P; Ledjiar O; Athale U; Rayar M; Kulkarni K; Truong T; Cellot S; Bittencourt H; Pelland-Marcotte MC; Tran TH
    Leuk Lymphoma; 2022 Dec; 63(13):3208-3216. PubMed ID: 36067507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
    Mejstrikova E; Volejnikova J; Fronkova E; Zdrahalova K; Kalina T; Sterba J; Jabali Y; Mihal V; Blazek B; Cerna Z; Prochazkova D; Hak J; Zemanova Z; Jarosova M; Oltova A; Sedlacek P; Schwarz J; Zuna J; Trka J; Stary J; Hrusak O
    Haematologica; 2010 Jun; 95(6):928-35. PubMed ID: 20145275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
    Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS; Porter CC; Castellino SM; Graham DK; Bhasin M
    Genome Med; 2023 Oct; 15(1):83. PubMed ID: 37845689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic aberration in mixed-phenotype acute leukemia in children: A single-center retrospective review.
    Chang TY; Chen SH; Jaing TH; Yang SH; Wen YC; Yang CP; Hung IJ
    Pediatr Neonatol; 2021 Jan; 62(1):21-25. PubMed ID: 32859541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C.
    Pelland-Marcotte MC; Kulkarni K; Athale UH; Pole JD; Brandão LR; Sung L
    Am J Hematol; 2021 Jul; 96(7):796-804. PubMed ID: 33848369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation between karyotypic characteristics and treatment outcome in childhood acute lymphoblastic leukemia].
    Tie LJ; Gu LJ; Chen J; Dong L; Chen J; Pan C; Ye H; Xue HL; Tang JY; Wang YP
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):339-43. PubMed ID: 16875587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult mixed phenotype acute leukemia (MPAL): B/myeloid MPAL
    Weinberg OK; Dennis J; Zia H; Chen P; Chu A; Koduru P; Luu HS; Fuda F; Chen W
    Int J Lab Hematol; 2023 Apr; 45(2):170-178. PubMed ID: 36325594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia-like treatment regimen provides better response in mixed phenotype acute leukemia: a comparative study between adults and pediatric MPAL patients.
    Rasekh EO; Osman R; Ibraheem D; Madney Y; Radwan E; Gameel A; Abdelhafiz A; Kamel A; Elfishawi S
    Ann Hematol; 2021 Mar; 100(3):699-707. PubMed ID: 33230570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc finger protein 384 (
    Sudutan T; Erbilgin Y; Hatirnaz Ng O; Karaman S; Karakas Z; Kucukcankurt F; Celkan T; Timur C; Ozdemir GN; Hacısalihoglu S; Gelen SA; Sayitoğlu M
    Leuk Lymphoma; 2022 Dec; 63(12):2931-2939. PubMed ID: 35921545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of Philadelphia chromosome in mixed phenotype acute leukemia (MPAL): A cancer registry analysis on real-world outcome.
    Qasrawi A; Ramlal R; Munker R; Hildebrandt GC
    Am J Hematol; 2020 Sep; 95(9):1015-1021. PubMed ID: 32419244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of pediatric mixed phenotype acute leukemia treated with lymphoid directed therapy: Analysis of an institutional series from India.
    Seetharam S; Thankamony P; Gopakumar KG; Nair RA; Jacob PM; Jagathnath Krishna KM; Rajeswari B; Nair M; Guruprasad CS; Prasanth VR
    Pediatr Hematol Oncol; 2021 May; 38(4):358-366. PubMed ID: 33635170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in childhood acute lymphoblastic leukemia in Japan. Japan Association of Childhood Leukemia Study.
    Horibe K; Hara J; Yagi K; Tawa A; Komada Y; Oda M; Nishimura S; Ishikawa Y; Kudoh T; Ueda K
    Int J Hematol; 2000 Jul; 72(1):61-8. PubMed ID: 10979211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes.
    Takahashi K; Wang F; Morita K; Yan Y; Hu P; Zhao P; Zhar AA; Wu CJ; Gumbs C; Little L; Tippen S; Thornton R; Coyle M; Mendoza M; Thompson E; Zhang J; DiNardo CD; Jain N; Ravandi F; Cortes JE; Garcia-Manero G; Kornblau S; Andreeff M; Jabbour E; Bueso-Ramos C; Takaori-Kondo A; Konopleva M; Patel K; Kantarjian H; Futreal PA
    Nat Commun; 2018 Jul; 9(1):2670. PubMed ID: 29991687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Philadelphia chromosome-positive mixed phenotype acute leukemia in the imatinib era.
    Shimizu H; Yokohama A; Hatsumi N; Takada S; Handa H; Sakura T; Nojima Y
    Eur J Haematol; 2014 Oct; 93(4):297-301. PubMed ID: 24750307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed-phenotype acute leukemia: A cohort and consensus research strategy from the Children's Oncology Group Acute Leukemia of Ambiguous Lineage Task Force.
    Orgel E; Alexander TB; Wood BL; Kahwash SB; Devidas M; Dai Y; Alonzo TA; Mullighan CG; Inaba H; Hunger SP; Raetz EA; Gamis AS; Rabin KR; Carroll AJ; Heerema NA; Berman JN; Woods WG; Loh ML; Zweidler-McKay PA; Horan JT;
    Cancer; 2020 Feb; 126(3):593-601. PubMed ID: 31661160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation for adult patients with mixed phenotype acute leukemia: results of a matched-pair analysis.
    Shimizu H; Saitoh T; Machida S; Kako S; Doki N; Mori T; Sakura T; Kanda Y; Kanamori H; Miyawaki S; Okamoto S;
    Eur J Haematol; 2015 Nov; 95(5):455-60. PubMed ID: 25605541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.
    Nachman JB; Heerema NA; Sather H; Camitta B; Forestier E; Harrison CJ; Dastugue N; Schrappe M; Pui CH; Basso G; Silverman LB; Janka-Schaub GE
    Blood; 2007 Aug; 110(4):1112-5. PubMed ID: 17473063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Incidence of TdT-negative Pre-B Acute Lymphoblastic Leukemia Associated With Poor Prognostic Features Among Mexican Children in Central Mexico.
    Vacek M; Zárraga Vargas LC; González Domínguez E; Garcia Rodriguez L; Tello Teran OA; Mojica Cardoso C; Ocampo Roosens LV; Acevedo Fernandez JJ; Li W; Lee B; Olalla Tapia JS; Flatt T
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e131-e136. PubMed ID: 38132672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
    Myint HH; Tandon S; Narula G; Prasad M; Subramanian P; Patkar N; Tembhare P; Gujral S; Banavali S
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):415-419. PubMed ID: 32976349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.